<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>47</viewCount><searchCount>0</searchCount></scores><additional><submitter>Zhao S</submitter><funding>NICHD NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>1037-1052</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5175409</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(4)</volume><pubmed_abstract>Mechanisms of metabolic flexibility enable cells to survive under stressful conditions and can thwart therapeutic responses. Acetyl-coenzyme A (CoA) plays central roles in energy production, lipid metabolism, and epigenomic modifications. Here, we show that, upon genetic deletion of Acly, the gene coding for ATP-citrate lyase (ACLY), cells remain viable and proliferate, although at an impaired rate. In the absence of ACLY, cells upregulate ACSS2 and utilize exogenous acetate to provide acetyl-CoA for de novo lipogenesis (DNL) and histone acetylation. A physiological level of acetate is sufficient for cell viability and abundant acetyl-CoA production, although histone acetylation levels remain low in ACLY-deficient cells unless supplemented with high levels of acetate. ACLY-deficient adipocytes accumulate lipid in vivo, exhibit increased acetyl-CoA and malonyl-CoA production from acetate, and display some differences in fatty acid content and synthesis. Together, these data indicate that engagement of acetate metabolism is a crucial, although partial, mechanism of compensation for ACLY deficiency.</pubmed_abstract><journal>Cell reports</journal><pubmed_title>ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.</pubmed_title><pmcid>PMC5175409</pmcid><funding_grant_id>P30 CA016520</funding_grant_id><funding_grant_id>P30 ES013508</funding_grant_id><funding_grant_id>T32 CA115299</funding_grant_id><funding_grant_id>K22 ES026235</funding_grant_id><funding_grant_id>R21 HD087866</funding_grant_id><funding_grant_id>K12 GM081259</funding_grant_id><funding_grant_id>R01 CA188652</funding_grant_id><funding_grant_id>R01 GM102503</funding_grant_id><funding_grant_id>P30 CA006927</funding_grant_id><funding_grant_id>R01 CA174761</funding_grant_id><funding_grant_id>F31 CA189744</funding_grant_id><pubmed_authors>Campbell SL</pubmed_authors><pubmed_authors>Wallace M</pubmed_authors><pubmed_authors>Carrer A</pubmed_authors><pubmed_authors>Wellen KE</pubmed_authors><pubmed_authors>Trefely S</pubmed_authors><pubmed_authors>Andrews AJ</pubmed_authors><pubmed_authors>Blair IA</pubmed_authors><pubmed_authors>Viola JM</pubmed_authors><pubmed_authors>Henry RA</pubmed_authors><pubmed_authors>Frey AJ</pubmed_authors><pubmed_authors>Metallo CM</pubmed_authors><pubmed_authors>Lee JV</pubmed_authors><pubmed_authors>Sengupta A</pubmed_authors><pubmed_authors>Kuo YM</pubmed_authors><pubmed_authors>Meurs N</pubmed_authors><pubmed_authors>Zhao S</pubmed_authors><pubmed_authors>Weljie AM</pubmed_authors><pubmed_authors>Snyder NW</pubmed_authors><pubmed_authors>Torres A</pubmed_authors><view_count>47</view_count></additional><is_claimable>false</is_claimable><name>ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.</name><description>Mechanisms of metabolic flexibility enable cells to survive under stressful conditions and can thwart therapeutic responses. Acetyl-coenzyme A (CoA) plays central roles in energy production, lipid metabolism, and epigenomic modifications. Here, we show that, upon genetic deletion of Acly, the gene coding for ATP-citrate lyase (ACLY), cells remain viable and proliferate, although at an impaired rate. In the absence of ACLY, cells upregulate ACSS2 and utilize exogenous acetate to provide acetyl-CoA for de novo lipogenesis (DNL) and histone acetylation. A physiological level of acetate is sufficient for cell viability and abundant acetyl-CoA production, although histone acetylation levels remain low in ACLY-deficient cells unless supplemented with high levels of acetate. ACLY-deficient adipocytes accumulate lipid in vivo, exhibit increased acetyl-CoA and malonyl-CoA production from acetate, and display some differences in fatty acid content and synthesis. Together, these data indicate that engagement of acetate metabolism is a crucial, although partial, mechanism of compensation for ACLY deficiency.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Oct</publication><modification>2020-10-31T09:11:06Z</modification><creation>2019-03-27T02:32:12Z</creation></dates><accession>S-EPMC5175409</accession><cross_references><pubmed>27760311</pubmed><doi>10.1016/j.celrep.2016.09.069</doi></cross_references></HashMap>